هالسهم حسب ما فهمت من الايميل الي وصلني سهم شركه طبيه ينتظر موافقه هيئه الدواء الامريكيه fda
سعر السهم اليوم
Please begin your research here: http://www.quantrx.com/
QTXB (QuantRX Biomedical Corp.) is our New SGW FDA Decision Report! QTXB closed Thursday at .09.
السهم مسكر امس 0.09 سنت و اليوم وصل لي 0.17 سنت بارتفاع اكثر من 88%
الله الموفق و اسف على التاخير لاني توني اشوف الايميل الي وصلني من الموقع
Many investors should remember the FDA craze that rung around the trading community around this time last year, providing immense gains in relatively short periods of time. Some examples include NEPH (.03 to 2.25+ in under 4 months) and BIEL (.002 to .10+ in just over 4 months). Both of these company's price ran on hype of their 510k FDA submission.
A 510k application is for medical device clearance, allowing the product to be placed on store shelves. In simpler terms, PDUFA dates are for drugs, and 510k applications are for medical devices. “In order to be eligible for 510(k) clearance, the new device must exhibit roughly the same safety and effectiveness characteristics as the “predicate” device to which the new one is being compared.”
سعر السهم اليوم
Please begin your research here: http://www.quantrx.com/
QTXB (QuantRX Biomedical Corp.) is our New SGW FDA Decision Report! QTXB closed Thursday at .09.
السهم مسكر امس 0.09 سنت و اليوم وصل لي 0.17 سنت بارتفاع اكثر من 88%
الله الموفق و اسف على التاخير لاني توني اشوف الايميل الي وصلني من الموقع
Many investors should remember the FDA craze that rung around the trading community around this time last year, providing immense gains in relatively short periods of time. Some examples include NEPH (.03 to 2.25+ in under 4 months) and BIEL (.002 to .10+ in just over 4 months). Both of these company's price ran on hype of their 510k FDA submission.
A 510k application is for medical device clearance, allowing the product to be placed on store shelves. In simpler terms, PDUFA dates are for drugs, and 510k applications are for medical devices. “In order to be eligible for 510(k) clearance, the new device must exhibit roughly the same safety and effectiveness characteristics as the “predicate” device to which the new one is being compared.”
